Full video transcriptClick to expand
Auto-generated transcript of @charlie_brand_music's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I did it all for the lucky, all the lucky, all so you can take that cookie
- 0:05It's taking a cookie, it's taking a cookie
Melanotan II for tanning: what the hype leaves out
Quick answer
Melanotan II is a non-selective melanocortin receptor agonist with documented effects on pigmentation, sexual arousal, appetite, and cardiovascular tone, none of which are FDA-approved indications. The video presents the tanning outcome without referencing the multi-system receptor activity or the documented risks associated with gray-market sourcing. Clinical use of MC1R-targeted peptides remains investigational, and no approved formulation of melanotan II exists in the US, UK, or EU.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Melanotan II for tanning: what the hype leaves out, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Melanotan II for tanning: what the hype leaves out is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Melanotan II for tanning: what the hype leaves out" from charlie_brand_music. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Melanotan II is a non-selective melanocortin receptor agonist with documented effects on pigmentation, sexual arousal, appetite, and cardiovascular tone, none of which are FDA-approved indications.
The reason this review is not generic is the source wording and the canonical claim label "peptides mt2 got me looking like the fresh prince of bellhend mt2 glo." In this clip, the useful excerpt is: "I did it all for the lucky, all the lucky, all so you can take that cookie It's taking a cookie, it's taking a cookie" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against SCENESSE (afamelanotide implant) FDA Prescribing Information (2019), Afamelanotide for Erythropoietic Protoporphyria (2015), and Melanotan II injection resulting in systemic toxicity and rhabdomyolysis (2012), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Melanotan II is a non-selective melanocortin receptor agonist with documented effects on pigmentation, sexual arousal, appetite, and cardiovascular tone, none of which are FDA-approved indications.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Melanotan II is a non-selective melanocortin receptor agonist with documented effects on pigmentation, sexual arousal, appetite, and cardiovascular tone, none of which are FDA-approved indications. The video presents the tanning outcome without referencing the multi-system receptor activity or the documented risks associated with gray-market sourcing. Clinical use of MC1R-targeted peptides remains investigational, and no approved formulation of melanotan II exists in the US, UK, or EU.
- Melanotan II binds at least 5 melanocortin receptor subtypes (MC1R-MC5R), meaning tanning is one effect among many, not the only effect.
- Wessells et al. (2000, Journal of Urology) reported spontaneous erections and nausea as significant adverse events in MT2 clinical trials, which ended further development for cosmetic indications.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Melanotan II binds at least 5 melanocortin receptor subtypes (MC1R-MC5R), meaning tanning is one effect among many, not the only effect.
- Wessells et al. (2000, Journal of Urology) reported spontaneous erections and nausea as significant adverse events in MT2 clinical trials, which ended further development for cosmetic indications.
- A 2022 analysis by Brennan et al. (Drug Testing and Analysis) found contamination and concentration errors in a meaningful share of gray-market melanotan products tested.
- Neither the FDA, MHRA, nor TGA has approved any formulation of melanotan II for any medical or cosmetic indication.
- King et al. (2005, Journal of Investigative Dermatology) raised documented concerns about MT2 stimulating existing moles, a risk that requires dermatological monitoring that no gray-market user is receiving.
- The EMA and MHRA have both issued formal warnings against online melanotan products, citing both the pharmacological risks and the uncontrolled manufacturing conditions.
- Self-tanning cosmetics and professional spray tans achieve a bronzed appearance without any receptor activation, peptide injection, or contamination risk.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @charlie_brand_music actually say?
Honestly? Not much of anything medically useful. The transcript is a Limp Bizkit lyric riff, and the caption does the real talking: "MT2 got me looking like the fresh prince of bellhend" with hashtags for MT2, tanning, and glow-up. So the claim is essentially visual and anecdotal. MT2 (melanotan II) made this person tan, and they liked the result enough to post about it. That is the entire thesis. There are no dosing claims, no disease cure claims, and no stack recommendations. But the casual, comedic framing is worth scrutinizing on its own, because it normalizes an unregulated peptide to 1,100 viewers without a single safety caveat.
This is the pattern that regulators and dermatologists lose sleep over. Not the outright lies, but the cheerful shrug. The implication that MT2 is just a fun tanning hack, no different from bronzer, is doing a lot of work in a very short video.
Does the science back this up?
Melanotan II does cause tanning. That part is real, and the mechanism is well-understood. The problem is everything that comes with it. MT2 is a synthetic analogue of alpha-melanocyte-stimulating hormone (a-MSH) that binds melanocortin receptors (MC1R through MC5R), triggering melanogenesis. Studies confirm the pigmentation effect, but the receptor promiscuity is the issue.
Wessells et al. (2000, Journal of Urology) documented spontaneous erections as a significant side effect in clinical trials, which is why MT2 was eventually shelved in favor of PT-141 (bremelanotide) for sexual dysfunction research. King et al. (2005, Journal of Investigative Dermatology) raised concerns about MT2 stimulating existing nevi, with case reports linking unsupervised use to dysplastic nevus changes. The peptide has never cleared Phase III clinical trials for any indication. The European Medicines Agency and the UK's MHRA have both issued warnings against melanotan products sold online, noting impurity risks in unregulated batches on top of the intrinsic pharmacological risks.
What did they get wrong (or right)?
Credit where it is due: the video makes no medical claims. No one said MT2 treats a disease, prevents cancer, or should be taken at a specific dose. The tanning effect is real and documented. If the only bar is "did MT2 produce visible tanning," then yes, the implicit claim is accurate.
What the video gets wrong, by omission, is substantial. MT2 is not a cosmetic product. It is an injectable peptide that is not approved by the FDA, MHRA, or TGA for any use. Sourcing it outside a regulated pharmacy means you have no idea what is actually in the vial. A 2022 analysis by Brennan et al. (Drug Testing and Analysis) tested gray-market melanotan products and found contamination and mislabeled concentrations in a significant portion of samples. Beyond purity, the nausea, facial flushing, and spontaneous erections reported in clinical studies are not minor inconveniences. And the mole-stimulation concern is not theoretical. Presenting this as a glow-up without any of that context is genuinely misleading, even if unintentionally so.
What should you actually know?
If you are thinking about MT2 because a TikTok made it look fun, here is the short version. Melanotan II works by activating melanocortin receptors across multiple systems in the body, not just skin. That means the tanning comes with cardiovascular, sexual, and potentially dermatological side effects that vary based on your individual receptor expression and the purity of what you are injecting. The gray market supply chain for MT2 is poorly regulated and contamination is documented, not hypothetical.
No telehealth platform operating under LegitScript standards can prescribe or supply MT2 in its current regulatory status. If tanning is your goal, self-tanners and professional spray tans carry no receptor activation risk. If you have a legitimate medical condition involving melanocortin pathways, that conversation belongs with a board-certified endocrinologist or dermatologist, not a TikTok comment section. The "glow-up" framing strips away the clinical complexity that anyone injecting this peptide genuinely needs to understand.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
charlie_brand_music · TikTok creator
1.1K views on this video
MT2 got me looking like the fresh prince of bellhend! #mt2 #Glowup #tanning
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about melanotan ii binds at least 5 melanocortin receptor subtypes (mc1r-mc5r),?
Melanotan II binds at least 5 melanocortin receptor subtypes (MC1R-MC5R), meaning tanning is one effect among many, not the only effect.
What does the video say about wessells et al. (2000, journal of urology) reported spontaneous erections?
Wessells et al. (2000, Journal of Urology) reported spontaneous erections and nausea as significant adverse events in MT2 clinical trials, which ended further development for cosmetic indications.
What does the video say about a 2022 analysis by brennan et al. (drug testing?
A 2022 analysis by Brennan et al. (Drug Testing and Analysis) found contamination and concentration errors in a meaningful share of gray-market melanotan products tested.
What does the video say about neither the fda, mhra, nor tga has approved any formulation?
Neither the FDA, MHRA, nor TGA has approved any formulation of melanotan II for any medical or cosmetic indication.
What does the video say about king et al. (2005, journal of investigative dermatology) raised documented?
King et al. (2005, Journal of Investigative Dermatology) raised documented concerns about MT2 stimulating existing moles, a risk that requires dermatological monitoring that no gray-market user is receiving.
What does the video say about the ema?
The EMA and MHRA have both issued formal warnings against online melanotan products, citing both the pharmacological risks and the uncontrolled manufacturing conditions.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by charlie_brand_music, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.